Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stelara® and Tremfya® Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project

NCT02103361 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT02103361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02103361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stelara® and Tremfya® Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project
Lead sponsor
University of California, San Diego
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2013
Completion date
February 28, 2031
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, pregnancy, psoriasis, psoriatic arthritis